Los Angeles, CA -- (SBWIRE) -- 10/19/2022 -- Iohexol was first listed in Norway and Sweden in 1982. It is a kind of second-generation non-ionic monomeric contrast agent. Iopromide, Iomeprol, etc. Iohexol has low osmotic pressure, low toxicity to the nervous system, low contrast density, and good tolerance. It can be used for angiography, subarachnoid angiography, coronary angiography, spinal cord and femoral joints, urology angiography, and enhanced CT scanning. Etc., is the "gold standard" for evaluating various X-ray contrast agents in the medical community.
The global Iohexol API market size is estimated to be worth US$ 592.91 million in 2022 and is forecast to a readjusted size of US$ 885.41 million by 2028 with a CAGR of 6.91% during the forecast period 2022-2028. Original Drug accounting for 81.71% of the Iohexol API global market in 2021, is projected to value US$ 695.93 million by 2028, growing at a revised 6.37% CAGR from 2022 to 2028.
Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) https://www.qyresearch.com/sample-form/form/4594363/Global-Iohexol-API-Market-Research-Report-2022
North America Iohexol API market size was 1,643.2 MT in 2021, while APAC was 1,378.9 MT. The proportion of the North America was 39.63% in 2021, while APAC's percentage was 33.26%, and it is predicted that APAC market share will reach 35.17% in 2028, trailing a CAGR of 8.15% through the analysis period.
The global major manufacturers of Iohexol API include GE Healthcare, Otsuka Chemicals, Justesa Imagen, Starry Pharmaceutical, Haichang Pharmaceutical, and etc. In terms of revenue, the global three largest players hold a 86.52% market share of Iohexol API in 2021.
The research report has incorporated the analysis of different factors that augment the market's growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2017 to 2028. This section mentions the volume of production by region from 2017 to 2028. Pricing analysis is included in the report according to each type from the year 2017 to 2028, manufacturer from 2017 to 2022, region from 2017 to 2022, and global price from 2017 to 2028.
A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert's opinions have been taken to understand the market better.
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2017 to 2028. by Application segment also provides consumption during the forecast period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Key Players Mentioned in the Global Iohexol API Market Research Report:
GE Healthcare
Otsuka Chemicals
Justesa Imagen
Starry Pharmaceutical
Haichang Pharmaceutical
Global Iohexol API Market by Type:
Original Drug
Generic Drug
Global Iohexol API Market by Application:
Hospitals
Clinics
Key Questions Answered in the Report Include:
(1) This Iohexol API report gives all the information about the industry analysis, revenue, and overview, of this market.
(2) What will be the rate of increase in Iohexol API market size and growth rate by the end of the forecast period?
(3) What are the major global Iohexol API market trends influencing the development of the market?
(4) What are the vital results of SWOT analysis of the major players operating in the Iohexol API market?
(5) What are the potential growth opportunities and threats faced by Major competitors in the Iohexol API market?
(6) What are the market opportunities and threats faced by vendors in the Global Iohexol API market?
Request for customization in Report: https://www.qyresearch.com/customize-request/form/4594363/Global-Iohexol-API-Market-Research-Report-2022
About Us:
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert's resources (included energy automotive chemical medical ICT consumer goods etc.